Intraoperative conversion during video-assisted thoracoscopy does not constitute a treatment failure†

Fourdrain, Alex; Dominicis, Florence De; Iquille, Jules; Lafitte, Sophie; Merlusca, Geoni; Witte-Pfister, Alejandro; Meynier, Jonathan; Bagan, Patrick; Berna, Pascal

doi:10.1093/ejcts/ezy343

Cited by 26 publications

(14 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There has been no significant differences identified between dogs that had lung tumors removed via thoracoscopy or VATS or via open thoracotomy [50,52]. This is similar to the current human literature in which both morbidity and mortality outcomes appear to be similar for MIS versus open thoracotomy [58,59].…”

Section: Thoracoscopysupporting

confidence: 63%

“…Reasons for conversion include hemorrhage (intercostal artery), failure to maintain OLV and poor access/visualization due to location of the tumor [50,51]. This is slightly higher than conversion rates in the human literature (18%) for VATS resection of primary lung tumors [58]. Other complications include port site inflammation and infection; infection in these cases can extend into the thoracic cavity and result in pyothorax.…”

Section: Thoracoscopymentioning

confidence: 99%

See 1 more Smart Citation

Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats

Balsa

Culp

2019

Veterinary Sciences

View full text Add to dashboard Cite

Surgical management of neoplastic disease is common in veterinary medicine. Minimally invasive surgery (MIS) has gained widespread acceptance by veterinary surgeons and is experiencing rapid growth and frequency of use. Many neoplastic diseases in the abdomen and thorax of dogs and cats can be treated as effectively with MIS as with traditional open surgery. Additionally, MIS allows for less invasive options for organ biopsy in cancer patients either for initial diagnosis or for staging to inform prognosis and treatment. Despite the recent increase in MIS, additional research is required to further characterize the benefits to oncology patients and to ensure that surgical oncologic principles and patient outcomes are not compromised by the use of MIS.

show abstract

Section: Thoracoscopysupporting

confidence: 63%

Section: Thoracoscopymentioning

confidence: 99%

Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats

Balsa

Culp

2019

Veterinary Sciences

View full text Add to dashboard Cite

show abstract

“…Studying intraoperative conversion prospectively seems almost impracticable, so we aimed to evaluate retrospectively the short-term outcomes of patient treated with VATS with intraoperative conversion to thoracotomy compared with those treated with thoracotomy upfront. Following a propensity score analysis with adjustment (no matching), because of a more comorbid cohort of patient in the VATS with conversion group, we observed a 90-day mortality rate of 5.4% vs. 3.7% between the VATS conversion and Thoracotomy group respectively, without statistical significant difference (1). We enhanced this evaluation by assessing risk factors for postoperative mortality in the cohort, finding no differences related to the surgical approach (VATS with conversion vs. thoracotomy) after multivariate analysis (1).…”

mentioning

confidence: 90%

Intraoperative conversion: it happens, we should smartly deal with it

Fourdrain¹,

Leviel²,

Lafitte³

et al. 2019

J. Thorac. Dis.

Self Cite

View full text Add to dashboard Cite

show abstract

“…45 Conversion from minimally invasive to open surgery may not increase postoperative morbidity or mortality risk. 46 On the other hand, as robotic thoracic surgery is increasingly adopted, awareness of the risks inherent in this complex new technology has grown, and a group of European thoracic surgeons recently proposed a standardized training curriculum for young doctors. 47 Although robotic and other innovative surgical approaches such as uniportal or subxiphoid VATS are receiving more attention, their additional functional benefit is questionable, as traditional VATS incisions cause loss of only 5% of pulmonary function.…”

Section: Minimally Invasive Approachesmentioning

confidence: 99%

Early-Stage NSCLC: Advances in Thoracic Oncology 2018

Osarogiagbon¹,

Veronesi

Fang

et al. 2019

Journal of Thoracic Oncology

View full text Add to dashboard Cite

2018 was a banner year for all thoracic oncology, but especially for early-stage NSCLC. Three seminal events occurred in the approximately 18 months from mid-2017 to the end of 2018: in June 2017 at the American Society of Clinical Oncology Annual Meeting a small, relatively unheralded study from Max Diehn's group at Stanford University reported on the use of a novel "cancer personalized profiling by deep sequencing" circulating tumor-DNA technology to identify minimal residual disease in patients after curative-intent radiation or surgery for NSCLC; in April 2018 at the American Association for Cancer Research Annual Meeting, Drew Pardoll presented a small pilot study of 21 patients who had received two doses of preoperative nivolumab; in September 2018, at the 19th World Conference on Lung Cancer, Harry J. De Koning presented the long-awaited results of the Dutch-Belgian Lung Cancer Screening Trial (NELSON). These three seminal studies, along with others which are reviewed in this paper, promise to accelerate our progress towards a world in which lung cancer is identified early, more patients undergo curative-intent treatment that achieves the promised cure, and those at risk for failure after treatment are identified early, when the cancer remains most vulnerable. The day is around the corner when lung cancer is defanged and no longer the worldwide terror it currently is. We herein present an overview of the most recent body of work that moves us inexorably towards that day.

show abstract

Intraoperative conversion during video-assisted thoracoscopy does not constitute a treatment failure†

Cited by 26 publications

References 13 publications

Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats

Use of Minimally Invasive Surgery in the Diagnosis and Treatment of Cancer in Dogs and Cats

Intraoperative conversion: it happens, we should smartly deal with it

Early-Stage NSCLC: Advances in Thoracic Oncology 2018

Contact Info

Product

Resources

About